Enzo Health Secures $20M in Series A Funding to Automate Home Health Administrative Workflows

Enzo Health just pulled a clean $20M Series A out of the noise, and if you listen closely, you can hear the paperwork in home health starting to sweat. Lehi, Utah is not where you expect a quiet rebellion, but that is usually how these things start. Zach Newman and Travis Elnicky are not chasing headlines, they are chasing friction, and in post-acute care, friction has a way of quietly draining time, money, and patience until something finally breaks.

N47 led the round, with Gradient, Tandem Ventures, Rigby Watts & Company, Soma Capital, and Lionel Partners all stepping in with intent. Total funding now sits at $26M, which reads less like a vanity metric and more like a coordinated signal. Serious investors do not pile into administrative workflows unless those workflows are the choke point. In this case, they are.

Enzo Health is building an AI platform that handles referral intake, documentation, coding, and OASIS review. Not the flashy side of healthcare, but the side that determines whether providers get paid, stay compliant, and keep moving. This is where hours vanish and margins get thin. Enzo positions itself as the co-pilot, processing millions of patient charts, cutting documentation time by 45 percent, and lifting staff productivity by 40 percent. That is not incremental improvement, that is operational relief showing up on time.

Underneath the surface, there is a broader cast tightening the system. Tanner Smith is steering the financial side as Head of Finance, translating growth into something sustainable. Around them, an advisory layer brings weight from the field, with Bud Langham, Renee Picard Walsh, and Beau Sorensen adding decades of operational reality from home health and hospice. Not spectators, but people who have lived inside the constraints Enzo is now trying to remove.

The timing is not subtle. More than 10,000 Americans turn 65 every day, and the infrastructure supporting home-based care is feeling every bit of that pressure. Demand is rising fast, but the backend still runs on workflows that were never designed for this volume. Enzo is not trying to reinvent care delivery, it is targeting the administrative gravity that slows everything down. That is where AI stops being theoretical and starts being necessary.

There is a pattern here worth studying. You do not land a $20M Series A this early by pitching a distant vision. You get there by embedding into workflows that cannot afford failure. Enzo Health did not just identify friction, they reduced it in real terms and made themselves part of the system’s daily rhythm. That is how a product moves closer to becoming infrastructure.

With expansion into hospice and skilled nursing ahead, the complexity only increases. Same pressure points, higher stakes, wider surface area. The kind of environment where execution matters more than narrative, and where the companies that last are the ones that make hard things feel routine.